Caplight Directory>Companies>Find Therapeutics-preview>Findtherapeutics


Find Therapeutics

Find Therapeutics

Private
Saint-Laurent, QuebecHealthcare & Life Scienceshttp://findtherapeutics.com

Last Round

Convertible Debt

Sep 16, 2024

Total Funding Raised

$8.1M

Company Overview

Find Therapeutics is a clinical-stage biopharmaceutical company that develops next-generation therapies to treat inflammatory autoimmune diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

remyelination therapytasronetidedemyelinating diseasesmultiple sclerosispeptide therapeuticmyelin repairautoimmune diseasesfirst-in-class drugclinical-stage biotechdrug discovery platformNRP1 targetGPCR modulatorschronic optic neuropathytransmembrane peptides

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Find Therapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Find Therapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 16, 2024
SeedJun 8, 2020
View all Funding Rounds

Find Therapeutics Investors

Notable investors and investment history

InvestorRounds
CTI Life Sciences FundConvertible Debt
Investissement QuébecConvertible Debt
adMare BioInnovationsSeed, Convertible Debt
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 21, 2026

    Monthly visitors increased 210% MoM.

  • Jan 9, 2026

    Paul F. Truex steps down as Executive Chairman, remains on Board.

View all signals

Find Therapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Find Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Find Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint-Laurent, Quebec
Employee Range11
Year Founded2020
Last FundingSep 16, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.